Hepatic disease and the risk of mortality of Vibrio vulnificus necrotizing skin and soft tissue infections: A systematic review and meta-analysis

PLoS One. 2019 Oct 25;14(10):e0223513. doi: 10.1371/journal.pone.0223513. eCollection 2019.

Abstract

Background: Vibrio vulnificus necrotizing skin and soft tissue infections (VNSSTIs) are associated with a high mortality rate that varies remarkably with host susceptibility. Hepatic disease (HD) is considered the key risk factor for high VNSSTIs incidence and mortality; however, there is limited evidence in the literature to support this observation.

Methodology: We examined all reported cases of VNSSTIs and associated mortality rates between 1966 and mid-2018. The PubMed, Medline and Cochrane Library databases were systematically searched for observational studies on patients with VNSSTIs. Twelve studies with 1157 total patients with VNSSTIs were included in the analysis. From the pooled dataset, nearly half (46.8%) of the patients with VNSSTIs had HD. The mortality rate in HD patients with VNSSTIs was 53.9% (n = 292/542), which was considerably higher than the mortality rate of 16.1% (n = 99/615) in non-HD patients. Patients with HD contracted VNSSTIs were found to be two or more times (RR = 2.61, 95% CI = 2.14-3.19) as likely to die compared with those without HD. Besides, liver cirrhosis (LC), the end-stage HD, was confirmed to be a significant risk factor, with risk ratios of 1.84 (95% CI 1.21-2.79) and 2.00 (95% CI 1.41-2.85) when compared to non-LC and non-HD, respectively.

Conclusions: HD with or without LC can be associated with infections and complications from V. vulnificus. Clinicians should aggressively approach care and management of acutely and/or critically ill patients with VNSSTIs.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Humans
  • Incidence
  • Liver Diseases / complications*
  • Mortality
  • Odds Ratio
  • Skin Diseases, Bacterial / complications*
  • Skin Diseases, Bacterial / microbiology
  • Skin Diseases, Bacterial / mortality*
  • Soft Tissue Infections / complications*
  • Soft Tissue Infections / microbiology
  • Soft Tissue Infections / mortality*
  • Vibrio Infections / complications*
  • Vibrio Infections / microbiology
  • Vibrio Infections / mortality*
  • Vibrio vulnificus*

Grants and funding

This work was supported by grants from the Chang Gung Memorial Hospital, Taiwan (Grant Nos. CORPG 6E0021 to HHW and CORPG 6E0071-3 to KCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.